MedTex Ventures

MedTex Ventures operates as a venture capital firm with a strategic focus on early-stage medical device companies. The firm leverages a team with extensive backgrounds spanning the buy-side, sell-side, and medical technology industry to identify and support promising innovations. A key aspect of their operational strategy involves a partnership with Biotex, Inc., a medical technology product development accelerator, which aids in the sourcing, in-depth analysis, development, and active management of portfolio companies.

The firm was established in 2021 by John Fichthorn, who serves as Founder and Managing Partner, and Co-Founder and Chief Financial Officer Trevor Uhl. Fichthorn brings over two decades of experience in investment analysis and fund management, including founding Dialectic Capital Management. Uhl's background encompasses more than twenty years in investment management, with executive roles at prominent financial institutions and experience advising alternative investment firms. This foundation combines robust financial expertise with deep operational insight, notably augmented by Partner Ashok Gowda's proven track record in medical device development and commercialization.

MedTex Ventures actively seeks partnerships with early-stage medical device companies that typically possess functional prototypes, strong intellectual property, and operate within markets with defined reimbursement pathways, prior to their Series A funding. The firm’s overarching mission is encapsulated by its commitment to "Do Good While You Do Well," aiming to invest in the development of products that not only create a significant positive impact on human life but also yield exceptional financial returns for its investors, fostering future advancements in healthcare.